Literature DB >> 193992

The elimination of herpes simplex plaques by antibody and the emergence of resistant strains.

P R Pavan, F A Ennis.   

Abstract

Established type 1 HSV plaques were eliminated by antibody. Antibody had to remain in contact with infected cells for several days to have a maxi;mum effect. It did not prevent the production of viral induced antigens in a cell when applied after the cell was infected but did prevent the transmission of infection to contiguous cells. Strains which were resistant to elimination by antibody formed syncytia, did not grow to significantly higher titers than nonresistant strains, and were as easily neutralized by antiserum as nonresistant strains.

Mesh:

Substances:

Year:  1977        PMID: 193992

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Molecular genetics of herpes simplex virus. II. Mapping of the major viral glycoproteins and of the genetic loci specifying the social behavior of infected cells.

Authors:  W T Ruyechan; L S Morse; D M Knipe; B Roizman
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

2.  Experimental ulcerative herpetic keratitis. III. Evaluation of hyperimmune gammaglobulin therapy.

Authors:  C A Carter; D L Easty
Journal:  Br J Ophthalmol       Date:  1981-06       Impact factor: 4.638

3.  Antibody-mediated recovery from subcutaneous herpes simplex virus type 2 infection.

Authors:  J E Oakes; H Rosemond-Hornbeak
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

4.  Lymphocyte reactivity contributes to protection conferred by specific antibody passively transferred to herpes simplex virus-infected mice.

Authors:  J E Oakes; W B Davis; J A Taylor; W A Weppner
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

5.  Positive self regulation of cytotoxicity in human natural killer cells by production of interferon upon exposure to influenza and herpes viruses.

Authors:  J Y Djeu; N Stocks; K Zoon; G J Stanton; T Timonen; R B Herberman
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

6.  Establishment of HSV1 latency in immunodeficient mice facilitates efficient in vivo reactivation.

Authors:  Chandran Ramakrishna; Adrianna Ferraioli; Aleth Calle; Thanh K Nguyen; Harry Openshaw; Patric S Lundberg; Patrick Lomonte; Edouard M Cantin
Journal:  PLoS Pathog       Date:  2015-03-11       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.